ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

GH

Genetron Health at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Genetron Health takes part in 3 sessions at ESMO 2026 in Madrid, and exhibits at Booth 8029. Its sessions centre on cancer testing using circulating tumour DNA and RNA. They cover validation of a personalised test for residual cancer DNA, RNA-based tumour profiling and identifying ALK gene changes in lung cancer.

OrganizationESMO 2026 Attendance
GH
Genetron Health
Diagnostics & toolsExhibitor
Chinese precision oncology company offering cancer genomic profiling and early detection tests.
Booth
Exhibiting at Booth 8029
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Analytical validation of onco-transcan for whole-transcriptome RNA expression profiling and PAM50 subtyping in solid tumors
ePoster session 22
Breast cancerBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Clinical utility of FusionCapture RNA NGS for resolving ALK fusion variants to inform targeted therapy in lung cancer
ePoster session 17
Lung & thoracic cancersBiomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Genetron Health

Tell us what you sell and we’ll find the people at Genetron Health most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction